Compare J.B.Chemicals with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ORCHID PHARMA LTD - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ORCHID PHARMA LTD J.B.CHEMICALS/
ORCHID PHARMA LTD
 
P/E (TTM) x 14.9 -0.4 - View Chart
P/BV x 2.7 0.1 2,283.2% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 J.B.CHEMICALS   ORCHID PHARMA LTD
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ORCHID PHARMA LTD
Sep-13
J.B.CHEMICALS/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs363194 187.2%   
Low Rs25535 728.6%   
Sales per share (Unadj.) Rs169.1276.5 61.2%  
Earnings per share (Unadj.) Rs16.6-79.2 -21.0%  
Cash flow per share (Unadj.) Rs23.4-43.5 -53.9%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.553.9 319.8%  
Shares outstanding (eoy) m83.5770.45 118.6%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.80.4 441.2%   
Avg P/E ratio x18.6-1.4 -1,288.0%  
P/CF ratio (eoy) x13.2-2.6 -500.8%  
Price / Book Value ratio x1.82.1 84.4%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,8278,067 320.2%   
No. of employees `0003.82.8 134.7%   
Total wages/salary Rs m2,5112,527 99.4%   
Avg. sales/employee Rs Th3,747.46,956.1 53.9%   
Avg. wages/employee Rs Th665.7902.5 73.8%   
Avg. net profit/employee Rs Th367.8-1,993.0 -18.5%   
INCOME DATA
Net Sales Rs m14,13519,477 72.6%  
Other income Rs m366407 89.8%   
Total revenues Rs m14,50119,884 72.9%   
Gross profit Rs m2,1781,103 197.6%  
Depreciation Rs m5702,519 22.6%   
Interest Rs m355,227 0.7%   
Profit before tax Rs m1,940-6,236 -31.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m552-125 -441.1%   
Profit after tax Rs m1,387-5,580 -24.9%  
Gross profit margin %15.45.7 272.2%  
Effective tax rate %28.52.0 1,418.4%   
Net profit margin %9.8-28.7 -34.3%  
BALANCE SHEET DATA
Current assets Rs m10,47011,014 95.1%   
Current liabilities Rs m2,74932,060 8.6%   
Net working cap to sales %54.6-108.1 -50.6%  
Current ratio x3.80.3 1,108.6%  
Inventory Days Days5595 58.2%  
Debtors Days Days7834 231.4%  
Net fixed assets Rs m5,81129,440 19.7%   
Share capital Rs m167705 23.7%   
"Free" reserves Rs m14,2482,043 697.6%   
Net worth Rs m14,4163,800 379.4%   
Long term debt Rs m09,018 0.0%   
Total assets Rs m17,64946,510 37.9%  
Interest coverage x56.6-0.2 -29,294.2%   
Debt to equity ratio x02.4 0.0%  
Sales to assets ratio x0.80.4 191.3%   
Return on assets %8.1-0.8 -1,060.2%  
Return on equity %9.6-146.9 -6.6%  
Return on capital %13.7-3.7 -366.7%  
Exports to sales %037.9 0.0%   
Imports to sales %022.6 0.0%   
Exports (fob) Rs mNA7,378 0.0%   
Imports (cif) Rs mNA4,406 0.0%   
Fx inflow Rs m6,1647,513 82.0%   
Fx outflow Rs m1,3345,649 23.6%   
Net fx Rs m4,8291,865 259.0%   
CASH FLOW
From Operations Rs m1,2311,682 73.2%  
From Investments Rs m-208-9,860 2.1%  
From Financial Activity Rs m-5956,644 -9.0%  
Net Cashflow Rs m427-1,535 -27.8%  

Share Holding

Indian Promoters % 55.4 32.3 171.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.6 73.7%  
FIIs % 3.9 3.3 118.2%  
ADR/GDR % 0.0 4.6 -  
Free float % 37.0 55.3 66.9%  
Shareholders   30,437 84,811 35.9%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Banking Stocks Fall(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.2% while the Hang Seng is down 0.4%.

Related Views on News

ADVANCED ENZYME TECHNOLOGIES Plunges by 5%; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Apr 3, 2020 | Updated on Apr 3, 2020

ADVANCED ENZYME TECHNOLOGIES share price has plunged by 5% and its current market price is Rs 133. The BSE HEALTHCARE is up by 0.6%. The top gainers in the BSE HEALTHCARE Index are FDC LTD. (up 6.1%) and SHILPA MEDICARE (up 5.0%). The top losers are ADVANCED ENZYME TECHNOLOGIES (down 5.3%) and J.B.CHEMICALS (down 7.8%).

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Apr 3, 2020 10:41 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - NOVARTIS COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS